This is a routine annual meeting proxy filing with no trading implications. Monitor for any subsequent 6-K filings that may contain clinical trial updates or financial results, which would be the primary catalysts for this clinical-stage biotech.
Price Chart
Executive Summary
Cardiol Therapeutics filed its management information circular and notice of annual general meeting for June 24, 2026. The filing is a routine proxy solicitation with standard items: election of eight directors, appointment of BDO Canada LLP as auditors, and receipt of audited financial statements. No material financial data, business developments, or strategic changes are disclosed.
Key Facts
- Annual general meeting scheduled for June 24, 2026, at 4:30 p.m. EDT, held virtually.
- Board proposes election of eight director nominees: David Elsley, Peter Pekos, Dr. Guillermo Torre-Amione, Colin Stott, Jennifer Chao, Christopher Waddick, Teri Loxam, and Dr. Timothy Garnett.
- Appointment of BDO Canada LLP as auditors for fiscal year ending December 31, 2026, with remuneration to be fixed by the Board.
- As of May 7, 2026 record date, 115,272,240 Class A common shares were issued and outstanding.
- MM Asset Management Inc. holds 15,352,317 shares (13.3%) and warrants for an additional 5,711,539 shares (17.4% partially diluted).
- No material financial results, guidance, or business updates are included in the filing.
Financial Impact
No financial impact — routine proxy filing with no new financial data or material events.
Risk Factors
- No material risks disclosed beyond standard corporate governance matters.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-066043 |
| Document: tm2615378d1_ex99-1.htm | 0001104659-26-066043 |
| Document: tm2615378d1_6k.htm | 0001104659-26-066043 |
| Document: tm2615378d1_ex99-3.htm | 0001104659-26-066043 |
| Document: tm2615378d1_ex99-4.htm | 0001104659-26-066043 |
| Document: 0001104659-26-066043-index-headers.html | 0001104659-26-066043 |
| Document: 0001104659-26-066043-index.html | 0001104659-26-066043 |
| Document: 0001104659-26-066043.txt | 0001104659-26-066043 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | SC 13G/A | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 23, 2026 4w ago | 6-K | $1.77 | awaiting T+60 | — | $1.14 (−35.59%) |
Sep 16, 2026 5w ago | 6-K | $1.90 | awaiting T+60 | — | $1.14 (−40.00%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 10, 2026 6w ago | 6-K | $2.00 | awaiting T+60 | — | $1.14 (−42.86%) |
Sep 9, 2026 6w ago | 6-K | $2.29 | awaiting T+60 | — | $1.14 (−50.11%) |
Aug 5, 2026 11w ago | 6-K | $1.34 | awaiting T+60 | — | $1.14 (−14.93%) |
Jul 14, 2026 15w ago | 6-K | $1.15 $1.32 | ▲ +14.78% | ▲ +11.41% | $1.14 (−0.87%) |
Jul 9, 2026 15w ago | 6-K | $0.9920 $1.41 | ▲ +42.14% | ▲ +40.50% | $1.14 (+14.92%) |
May 26, 2026 22w ago | 6-K | $1.30 $1.96 | ▲ +50.77% | ▲ +48.04% | $1.14 (−12.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers